Grants per year
- 250 - 269 out of 269 results
Search results
-
Finished
Prot# CEL220: A Phase IV, Single Center Pilot Study Using Alemtuzumab (CAMPATH-1H) Induction Combined with Prednisone-Free and Calcineurin-Inhibitor-Free Immunosuppression in Kidney Transplantation
Leventhal, J. R. (PD/PI) & Gallon, L. (Co-PD/PI)
1/25/05 → 11/1/11
Project: Research project
-
Immunophenotyping and Functional Profiles of Peripheral Lymphocytes in Renal Transplant Recipients After T-Cell Depletion with Alemtuzumab (Anti-CD52 Monoclonal Antibody)-Potential Implications for Safe Immunosuppressive Minimization
Gallon, L. (PD/PI)
Northwestern Memorial Foundation
1/1/05 → 12/31/08
Project: Research project
-
Immunophenotyping and Functional Profiles of Peripheral Lymphocytes in Renal Transplant Recipients After T-Cell Depletion with Alemtuzumab (Anti-CD52 Monoclonal Antibody)-Potential Implications for Safe Immunosuppressive Minimization
Gallon, L. (PD/PI)
Northwestern Memorial Foundation
1/1/05 → 12/31/08
Project: Research project
-
Mechanisms of Nocturnal Hypertension in Type I Diabetes
Batlle, D. (PD/PI)
11/1/04 → 4/30/07
Project: Research project
-
Mechanisms of Nocturnal Hypertension in Type I Diabetes
Batlle, D. (PD/PI)
11/1/04 → 4/30/07
Project: Research project
-
Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT): A Randomized, Controlled Clinical Trial of the Effect of a High Dose Combination of Folic Acid, Vitamin B6 and Vitamin B12, on Arteriosclerotic Cardiovascular Disease Outcomes in Chro
Searle Funds at The Chicago Community Trust
10/1/04 → 1/31/09
Project: Research project
-
Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT): A Randomized, Controlled Clinical Trial of the Effect of a High Dose Combination of Folic Acid, Vitamin B6 and Vitamin B12, on Arteriosclerotic Cardiovascular Disease Outcomes in Chro
Gallon, L. (PD/PI), Abecassis, M. M. (Co-PD/PI) & Leventhal, J. R. (Co-PD/PI)
Rhode Island Hospital, National Institute of Diabetes and Digestive and Kidney Diseases
10/1/04 → 1/31/09
Project: Research project
-
Molecular Profiling and Immunomodulatory Intervention
Abecassis, M. M. (PD/PI), Friedewald, J. J. (Co-PD/PI), Gallon, L. (Co-PD/PI), Kulik, L. M. (Co-PD/PI) & Friedewald, J. J. (Co-Investigator)
University of Pennsylvania, National Institute of Allergy and Infectious Diseases
9/15/04 → 8/31/11
Project: Research project
-
Desensitization of Cross Match Positive Renal Transplant Recipients Using Alemtuzumab: An Investigator Initiated Proposal (ICAM085)
Leventhal, J. R. (PD/PI) & Gallon, L. (Co-PD/PI)
8/20/04 → 1/14/10
Project: Research project
-
Desensitization of Cross Match Positive Renal Transplant Recipients Using Alemtuzumab: An Investigator Initiated Proposal (ICAM085)
Leventhal, J. R. (PD/PI) & Gallon, L. (Co-PD/PI)
8/20/04 → 1/14/10
Project: Research project
-
Prot# M03-601: Evaluation of the Safety, Tolerability and Pharmacokinetic Profiles of Single Rising Doses and Increasing Administration Rates of Intravenous ABT-870 in ESRD Subjects on Chronic Hemodialysis with Iron Deficiency Anemia
Schlueter, W. A. (PD/PI) & Batlle, D. (Co-PD/PI)
Paragon Biomedical, Inc., Abbott Laboratories
7/13/04 → 1/13/06
Project: Research project
-
Immunophenotyping and Functional Profiles of Peripheral Lymphocytes in Renal Transplant Recipients After T-Cell Depletion With Alemtuzumab (Anti-CD52 Monoclonal Antibody)-Potential Implications for Safe Immunosuppressive Minimization
Gallon, L. (PD/PI)
American Society of Transplantation
7/1/04 → 5/31/11
Project: Research project
-
Prot# Nabi-1371: A Phase 3 Multicenter, Randomized, Placebo-Controlled, Double-Blinded Study to Evaluate Efficacy of StaphVAX®, A Bivalent Staphylococcus aureus Glycoconjugate Vaccine in Adults on Hemodialysis
Batlle, D. (PD/PI) & Schlueter, W. A. (Co-PD/PI)
4/13/04 → 4/13/06
Project: Research project
-
Prot# M02-516: A Phase IV, Prospective, Randomized, Active-Controlled, Double-Blind, Double-Dummy, Multi-Center Study to Evaluate the Survival Benefits of Zemplar Relative to Calcijex in Subjects w/ Stage V Chronic Kidney Disease on Hemodialysis
Batlle, D. (PD/PI) & Schlueter, W. A. (Co-PD/PI)
Paragon Biomedical, Inc., Abbott Laboratories
2/10/04 → 2/9/09
Project: Research project
-
Prot# CRAD001A US09: A Prospective, Multicenter, Open-Label, Randomized Study of Safety, Tolerability & Efficacy of Certican® (RAD001) w/ Simulect®, Corticosteroids & Lower Levels Versus Higher Levels of Tacrolimus in de novo Renal Transplant Recipients
Abecassis, M. M. (PD/PI), Gallon, L. (Co-PD/PI) & Leventhal, J. R. (Co-PD/PI)
Novartis Pharmaceuticals Corporation
10/17/03 → 4/30/05
Project: Research project
-
Post Marketing Surveillance Study for LDL Apheresis Using H.E.L.P. (Heparin-Induced Extracorporeal Lipoprotein Precipitation) Therapy
Schlueter, W. A. (PD/PI)
12/6/02 → 5/4/10
Project: Research project
-
Stem Cell Transplantation for Treatment of Autoimmune Diseases
Burt, R. K. (PD/PI), Pope, R. M. (Co-PD/PI) & Rosa, R. M. (Co-PD/PI)
National Institute of Allergy and Infectious Diseases
9/30/99 → 10/18/08
Project: Research project
-
Stem Cell Transplantation for Treatment of Autoimmune Diseases
Burt, R. K. (PD/PI), Pope, R. M. (Co-PD/PI) & Rosa, R. M. (Co-PD/PI)
National Institute of Allergy and Infectious Diseases
9/30/99 → 10/18/08
Project: Research project